The electrophysiology devices market was valued at US$ 6,513.3 Mn in 2017 and projected to reach US$ 16,730.2 Mn by 2026 at a CAGR of 10.9% over the forecast period from 2018 to 2026.
—
The latest market report published by Credence Research, Inc. “Electrophysiology Devices Market Growth, Future Prospects, and Competitive Analysis, 2018–2026” the market for electrophysiology devices was valued at US$ 6,513.3 million in 2017 and projected to reach US$ 16,730.2 million by 2026 at a CAGR of 10.9 percent over the forecast period from 2018 to 2026.
The market for electrophysiology (EP) devices is likely to witness a phenomenal CAGR during the 2018-2026 forecast period. Electrophysiology, the branch of physiology, is a test performed to assess the heart’s electrical system/activity and to diagnose abnormal heartbeats or arrhythmia. A growing aging population coupled with increasing prevalence of atrial fibrillation (AF) & cardiovascular diseases (CVDs), technological advancements in electrophysiology devices, and the presence of favorable government initiatives are factors driving market growth.
Browse the full report Electrophysiology Devices Market Growth, Future Prospects, and Competitive Analysis, 2018–2026 at https://www.credenceresearch.com/report/electrophysiology-devices-market
Technological developments in electrophysiology devices such as fluoroscopy integrated 3D mapping technology in ablation, a bidirectional duodecapolar diagnostic catheter, irrigated RF catheters and remote steering systems fuel the demand for EP devices. Additionally, novel techniques including convergent procedure, WATCHMAN left atrial appendage closure (LAAC) procedure, and focal impulse and rotor modulation (FIRM) are gaining momentum among patients and healthcare professionals (HCPs). On the contrary, high electrophysiology device costs and the availability of alternative therapies are expected to hinder market growth during the forecast period.
The introduction of the Million Hearts CVD Risk Reduction model that will bridge a gap in cardiovascular care by giving targeted incentives to health care providers (HCPs) or practitioners to engage in beneficiary cardiovascular disease (CVD) risk calculation and population-level risk management is supposed to support market growth. Globally, electrophysiology devices market to witness a profitable growth with a CAGR of 10.9 percent over the forecast period from 2018 to 2026.
The electrophysiology ablation catheters segment would follow the electrophysiology laboratory devices in terms of revenue based on the product. Due to the advent of implantable cardiac monitors to monitor atrial fibrillation, the cardiac monitor segment will exhibit the fastest CAGR during the forecast period. Increasing the prevalence of atrial fibrillation (Afib) worldwide coupled with increasing adoption of electrophysiology devices and procedures would support the supremacy of the atrial fibrillation indication throughout the 2017 forecast period and maintain its status quo throughout the forecast period due to the presence of key market participants & target.
The rising prevalence of atrial fibrillation (Afib) across the world coupled with increasing adoption of electrophysiology devices and procedures would support the supremacy of the atrial fibrillation indication throughout the forecast period
North America commanded the market in 2017 and would retain its status quo throughout the forecast period due to the presence of key market participants & target population, and favorable reimbursement & coverage scenario for electrophysiology procedures in the U.S. and Canada
Asia Pacific is foreseen to demonstrate comparatively higher CAGR during the forecast period between 2018 & 2026 due to surging elderly population base coupled with increasing prevalence of atrial fibrillation, Wolff-Parkinson-White (WPW) syndrome, and cardiovascular diseases in India, China, Japan, and Australia
Major players in this vertical are Siemens Healthineers; Medtronic plc; Boston Scientific Corporation; Abbott Laboratories; Biosense Webster, Inc. (Johnson & Johnson Services, Inc.); BIOTRONIK SE & Co. KG; Nihon Kohden Corporation; MicroPort Scientific Corporation; CardioFocus, Inc.; and Stereotaxis, Inc.
Get Sample (Free) @ https://www.credenceresearch.com/sample-request/59377
ToC:
Chapter 1 Preface
1.1 Report Scope and Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Approaches Adopted
1.3.4.1 Top-Down Approach
1.3.4.2 Bottom-Up Approach
1.3.5 Assumptions
1.4 Market Segmentation
Chapter 2 Executive Summary
…………
Chapter 3 Market Dynamics
…………
Chapter 4 Global Electrophysiology Devices Market, by Product, 2016–2026 (US$ Mn)
4.1 Overview
4.2 Electrophysiology Laboratory Devices
4.2.1 Electrophysiology X-Ray Systems
4.2.2 Electrophysiology Imaging, Mapping & Recording Systems
4.2.3 Intracardiac Echocardiography (ICE) Systems
4.2.4 Radiofrequency (RF) Ablation Generators
4.2.5 Electrophysiology Remote Steering Systems
4.3 Electrophysiology Ablation Catheters
4.4 Electrophysiology Diagnostic Catheters
4.4.1 Fixed Diagnostic Catheters
4.4.2 Steerable Diagnostic Catheters
4.5 Cardiac Monitors
4.6 Cardiac Resynchronization Therapy Devices (CRTs)
4.7 Implantable Cardioverter Defibrillators (ICDs)
4.8 Access Devices
4.9 Left Atrial Appendage (LAA) & Closure Devices
Chapter 5 Global Electrophysiology Devices Market, by Indication, 2016–2026 (US$ Mn)
5.1 Overview
5.2 Atrial Fibrillation (AF)
5.3 Atrial Flutter (AFL)
5.4 Wolff-Parkinson-White (WPW) Syndrome
5.5 Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
5.6 Others (retinal diseases and optic nerve diseases)
Chapter 6 Global Electrophysiology Devices Market, by Geography, 2016–2026 (US$ Mn)
…………..
Chapter 7 Company Profiles
7.1 Siemens Healthineers
7.2 Medtronic plc
7.3 Boston Scientific Corporation
7.4 Abbott Laboratories
7.5 Biosense Webster, Inc. (Johnson & Johnson Services, Inc.)
7.6 BIOTRONIK SE & Co. KG
7.7 Nihon Kohden Corporation
7.8 MicroPort Scientific Corporation
7.9 CardioFocus, Inc.
7.10 Stereotaxis, Inc.
………………………..toc continued
Browse the full report Electrophysiology Devices Market Growth, Future Prospects, and Competitive Analysis, 2018–2026 at https://www.credenceresearch.com/report/electrophysiology-devices-market
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com
Source: MarketersMedia
Release ID: 498379
